Back to ExodusPoint Capital Management, LP ExodusPoint Capital Management, LP

KNSAKNSA
8 quarters

Position history for ExodusPoint Capital Management, LPExodusPoint Capital Management, LP's holdings in KINIKSA PHARMACEUTICALS INTL

ExodusPoint Capital Management, LP holds 33,017 shares of KNSA (KINIKSA PHARMACEUTICALS INTL), worth $2.1M as of 2026-Q2. The position was decreased (-36.9% shares). KNSA represents 0.0% of ExodusPoint Capital Management, LP's portfolio.

Current Value

$2.1M

Current Shares

33,017

Total Value Change

+$1.8M

Total Shares Change

+21,079

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
33,017
-36.9%
$2.1M0.0%$63.95
0
2026-Q1
Increased
52,303
+557.2%
$2.5M0.0%$45.37
42
2025-Q4
Decreased
7,958
-86.7%
$328,2680.0%$40.99
0
2025-Q3
Decreased
59,876
-55.1%
$2.3M0.0%$38.77
0
2025-Q2
Increased
133,276
+311.6%
$3.7M0.0%$28.04
43
2025-Q1
Decreased
32,382
-74.5%
$719,0000.0%$23.09
0
2024-Q4
Increased
127,161
+965.2%
$2.5M0.0%$19.60
42
2024-Q3
New
11,938
-
$298,0000.0%$25.00
32

Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used